Sanara MedTech, Inc. (SMTI)
35.09
+0.02
(+0.06%)
USD |
NASDAQ |
Oct 12, 09:56
Sanara MedTech Gross Profit Margin (Quarterly) : 90.76% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 90.76% |
| March 31, 2026 | 90.97% |
| December 31, 2025 | 90.77% |
| September 30, 2025 | 90.56% |
| June 30, 2025 | 89.82% |
| March 31, 2025 | 89.21% |
| December 31, 2024 | 88.82% |
| September 30, 2024 | 85.71% |
| June 30, 2024 | 84.55% |
| March 31, 2024 | 83.84% |
| December 31, 2023 | 83.70% |
| September 30, 2023 | 82.85% |
| June 30, 2023 | 81.01% |
| March 31, 2023 | 81.29% |
| December 31, 2022 | 79.22% |
| September 30, 2022 | 76.67% |
| June 30, 2022 | 84.52% |
| March 31, 2022 | 87.10% |
| December 31, 2021 | 86.01% |
| September 30, 2021 | 87.60% |
| June 30, 2021 | 89.85% |
| March 31, 2021 | 88.72% |
| December 31, 2020 | 88.06% |
| September 30, 2020 | 87.70% |
| June 30, 2020 | 85.75% |
| Date | Value |
|---|---|
| March 31, 2020 | 89.11% |
| December 31, 2019 | 89.64% |
| September 30, 2019 | 88.63% |
| June 30, 2019 | 88.16% |
| March 31, 2019 | 88.19% |
| December 31, 2018 | 88.05% |
| September 30, 2018 | 90.14% |
| June 30, 2018 | 92.05% |
| March 31, 2018 | 88.21% |
| December 31, 2017 | 85.98% |
| September 30, 2017 | 82.48% |
| June 30, 2017 | 87.26% |
| March 31, 2017 | 87.93% |
| December 31, 2016 | 80.15% |
| September 30, 2016 | 83.90% |
| June 30, 2016 | 82.08% |
| March 31, 2016 | 81.21% |
| December 31, 2015 | 59.35% |
| September 30, 2015 | 76.57% |
| June 30, 2015 | 70.45% |
| March 31, 2015 | 77.12% |
| December 31, 2014 | 80.09% |
| September 30, 2014 | 63.29% |
| June 30, 2014 | 47.92% |
| March 31, 2014 | 73.22% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Intelligent Bio Solutions, Inc. | 21.68% |
| Anteris Technologies Global Corp. | 30.43% |
| 20/20 Biolabs, Inc. | 41.71% |
| Quest Diagnostics, Inc. | 32.53% |
| Labcorp Holdings, Inc. | 27.71% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.29% |
| Return on Assets | -0.38% |
| Return on Invested Capital | -0.48% |
| Profit Margin (Quarterly) | -1.46% |
| Operating Margin (Quarterly) | 10.29% |
| Return on Net Operating Assets | -0.60% |